These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25215431)

  • 1. Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.
    Zhou SJ; Bai L; Lv L; Chen R; Li CJ; Liu XY; Yu DM; Yu P
    Mol Med Rep; 2014 Nov; 10(5):2587-94. PubMed ID: 25215431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
    Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
    Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
    Hendarto H; Inoguchi T; Maeda Y; Ikeda N; Zheng J; Takei R; Yokomizo H; Hirata E; Sonoda N; Takayanagi R
    Metabolism; 2012 Oct; 61(10):1422-34. PubMed ID: 22554832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells.
    Hattori Y; Jojima T; Tomizawa A; Satoh H; Hattori S; Kasai K; Hayashi T
    Diabetologia; 2010 Oct; 53(10):2256-63. PubMed ID: 20593161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation.
    Dai Y; Mehta JL; Chen M
    Cardiovasc Drugs Ther; 2013 Oct; 27(5):371-80. PubMed ID: 23657563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
    Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
    Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
    Grumbach IM; Chen W; Mertens SA; Harrison DG
    J Mol Cell Cardiol; 2005 Oct; 39(4):595-603. PubMed ID: 16099468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
    Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
    Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A; El-Moselhy MA; Taye A; Khalifa MM
    Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3,4-dihydroxyacetophenone on endothelial dysfunction in streptozotocin-induced rats with type 2 diabetes.
    Liu C; Sun J; Xue F; Yi Y; Han A
    J Cardiovasc Pharmacol; 2015 Jan; 65(1):22-7. PubMed ID: 25162436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats.
    Dalaklioglu S; Kuscu N; Celik-Ozenci C; Bayram Z; Nacitarhan C; Ozdem SS
    Fundam Clin Pharmacol; 2014 Aug; 28(4):394-404. PubMed ID: 23848484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential roles for eNOS and NrF₂ /HO-1 signaling in the ameliorative effect of lixisenatide on diabetes-induced kidney injury in rats and its amplification by ticagrelor co-administration.
    Sleem M; Aboubakr EM; Mohamed WR; Khalil AM; Messiha BAS; Taye A
    Pharmazie; 2024 Oct; 79(9):187-194. PubMed ID: 39407425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor κB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice.
    Mong MC; Yin MC
    J Agric Food Chem; 2012 Mar; 60(12):3158-65. PubMed ID: 22394022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.
    Jiang Y; Liu J; Zhou Z; Liu K; Liu C
    Med Sci Monit; 2018 Oct; 24():7007-7014. PubMed ID: 30278036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
    Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
    Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
    Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.